You are here
Inhaling respirable crystalline silica dust
Rheumatoid arthritis - Inhaling respirable crystalline silica dust Factor
Last reviewed for CCPS 22 December 2008.
Investigative Documents
Claimant Report - Inhaling Respirable Crystalline Silica Dust - Rheumatoid Arthritis [CR9309] Preliminary questions [34579]
34641 the veteran has inhaled respirable crystalline silica dust as defined in the Statements of Principles for rheumatoid arthritis at some time. 40346 — the veteran has established the causal connection between inhaling respirable crystalline silica dust and VEA service for rheumatoid arthritis. 34642 — the veteran has established the causal connection between inhaling respirable crystalline silica dust and VEA service for the clinical onset of rheumatoid arthritis. 34643 — the veteran has established the causal connection between inhaling respirable crystalline silica dust and operational service for the clinical onset of rheumatoid arthritis. or 34644 — the veteran has established the causal connection between inhaling respirable crystalline silica dust and eligible service for the clinical onset of rheumatoid arthritis. or 40347 — the veteran has established the causal connection between inhaling respirable crystalline silica dust and VEA service for the clinical worsening of rheumatoid arthritis. 40348 — the veteran has established the causal connection between inhaling respirable crystalline silica dust and operational service for the clinical worsening of rheumatoid arthritis. or 40349 — the veteran has established the causal connection between inhaling respirable crystalline silica dust and eligible service for the clinical worsening of rheumatoid arthritis. Clinical onset and operational service [34643] Clinical onset and eligible service [34644] Clinical worsening and operational service [40348] Clinical worsening and eligible service [40349]